The Global Antibiotic Resistance Partnership (GARP) is an initiative of the Center for Disease Dynamics, Economics and Policy (CDDEP). This is a not for profit organization that conducts independent research. The program began in 2009 to address the challenge of antibiotic resistance in low- and middle- income countries.
GARP working groups are country -led with guidance and collaboration from CDDEP. Research and policy directions are driven by local data, evidence and priorities. Country partners take the lead in managing the GARP process, with support from CDDEP. The GARP-Uganda secretariat is located at Uganda National Academy of Sciences (UNAS) and the working group is a standing committee of UNAS.
GARP Phase 1 culminated in the 1st Global Forum on Bacterial Infections: Balancing Treatment Access and Antibiotic Resistance, in New Delhi, India. Since GARP Phase 2 began in 2012, national working groups have been established in Mozambique, Nepal, Tanzania, and Uganda.
The GARP secretariat at the Center for Disease Dynamics, Economics and Policy (CDDEP), in Washington, DC, and New Delhi, provides technical support to each working group, creates links within the GARP network, and involves the working groups in global discussions and policy development.
GARP started in 2009 and in phases, Uganda is the last one and in the 2nd phase.
Drug Assessment and Registration Officer
© Uganda National Academy of Sciences. All rights reserved.
© Uganda National Academy of Sciences. All rights reserved.
Powered by Maeghan Ahumuza.